Greenland Capital Management LP Makes New $273,000 Investment in Hinge Health Inc. $HNGE

Greenland Capital Management LP purchased a new stake in Hinge Health Inc. (NYSE:HNGE) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 5,273 shares of the company’s stock, valued at approximately $273,000.

Other hedge funds have also modified their holdings of the company. CHURCHILL MANAGEMENT Corp bought a new position in Hinge Health during the 2nd quarter worth approximately $828,000. FNY Investment Advisers LLC acquired a new stake in Hinge Health in the second quarter worth $310,000. Strategic Blueprint LLC bought a new position in shares of Hinge Health during the second quarter worth $346,000. Emerald Advisers LLC acquired a new position in shares of Hinge Health in the 2nd quarter valued at $108,000. Finally, Mark Sheptoff Financial Planning LLC bought a new stake in shares of Hinge Health in the 2nd quarter valued at $114,000.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on HNGE. Robert W. Baird started coverage on Hinge Health in a research note on Friday, September 5th. They set a “neutral” rating and a $56.00 price objective on the stock. Needham & Company LLC raised their price target on Hinge Health from $47.00 to $59.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Barclays lifted their price objective on Hinge Health from $62.00 to $65.00 and gave the company an “overweight” rating in a report on Wednesday, November 5th. Morgan Stanley increased their target price on Hinge Health from $57.00 to $67.00 and gave the stock an “overweight” rating in a research note on Tuesday, September 23rd. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Hinge Health in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Hinge Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $59.93.

Insider Transactions at Hinge Health

In related news, Director Kristina M. Leslie sold 3,813 shares of the stock in a transaction that occurred on Wednesday, November 19th. The stock was sold at an average price of $43.60, for a total transaction of $166,246.80. Following the completion of the transaction, the director directly owned 29,000 shares of the company’s stock, valued at approximately $1,264,400. This represents a 11.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Hinge Health Stock Performance

NYSE HNGE opened at $44.25 on Thursday. The firm has a 50 day simple moving average of $50.21. Hinge Health Inc. has a 12-month low of $33.42 and a 12-month high of $62.18.

Hinge Health (NYSE:HNGE) last released its earnings results on Tuesday, November 4th. The company reported ($0.02) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.18. The business had revenue of $154.21 million during the quarter, compared to the consensus estimate of $142.44 million. The firm’s quarterly revenue was up 53.3% compared to the same quarter last year. Hinge Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS.

Hinge Health declared that its board has authorized a stock buyback program on Wednesday, November 12th that authorizes the company to buyback $250.00 million in outstanding shares. This buyback authorization authorizes the company to reacquire up to 7.2% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s leadership believes its shares are undervalued.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.